Dr Verena Hehle

Dr Verena Hehle, part of the Innovation Forum Executive team since January 2020, has over 11 years’ experience in a multidisciplinary context of therapeutic antibody discovery, molecular biology (human & plants) and infectious diseases with a good understanding of the pharmaceutical and
biotechnology industry. Verena obtained a PhD from St George’s University in London, investigating the enzymatic degradation of antibodies expressed in tobacco plants and did a postdoc at the Institut Pasteur, developing therapeutic antibodies against Hepatitis B. During these times she engaged in pro-bono activities for the British Science association, Pint of Science Paris and Hello Tomorrow. Verena is currently based in the Netherlands Utrecht at Biotechnology company called Merus N.V., developing Bispecific antibodies for oncology treatments.

Other team Members

Dr Piotr Gierszewski

View profile

Dr Bauke Anninga

Board Member, Innovation Forum

View profile

Roxana Sava

Business Development Manager

View profile

Dr Wen Hwa Lee

View profile

Beatrice Volpe

View profile
We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.